Browsing through the new social media filter service BuzzTrader, we note that Nexam is one of the most popular names discussed by Swedish investors over the last month. The list is led by names such as Kinnevik and NeuroVive Pharmaceutical and Nexam leaves Swedish bellwethers such as Ericsson and Sandvik behind.
BuzzTrader is a service that screens the information available in social media and different forums in real-time and bundles them into a sentiment analysis. It also allows you to collect all information in one source, without the hassle of having to look on several different pages.
Digging a bit deeper into the buzz around Nexam, we note that the majority written about the company has been positive, as could be expected following an encouraging Q2 report presented last week (http://nordicinvestor.net/2014/08/21/nexam-chemical-track-greatness/).
Interest in Nexam is high and the current share price levels could be a good entry point for mid- to long-term investors. Nexam is a very news-driven share and we expect the announcement of new patents and/or co-operations to to cause a sharp rebound. With the help of BuzzTrader, we know that many people are looking at Nexam.